Screening for West Nile Virus in Organ Transplantation: A Medical Decision Analysis

The Organ Procurement and Transplant Network (OPTN) has recently announced that screening for West Nile Virus (WNV) in deceased organ donors is not recommended at this time. The purpose of this report was to examine the impact of this recommendation by using medical decision analysis.

[1]  D. Smee,et al.  Identification of active antiviral compounds against a New York isolate of West Nile virus. , 2002, Antiviral research.

[2]  B. Sampson,et al.  West Nile Encephalitis , 2001, Annals of the New York Academy of Sciences.

[3]  C. Goodman.  United Network for Organ Sharing , 1988 .

[4]  Eld,et al.  COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS , PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION , AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT , 2000 .

[5]  P. Sampathkumar.  West Nile Virus: Epidemiology, Clinical Presentation, Diagnosis, and Prevention , 2003, Mayo Clinic Proceedings.

[6]  R. Lanciotti,et al.  Transmission of West Nile virus from an organ donor to four transplant recipients. , 2003, The New England journal of medicine.

[7]  R. Dodd.  Emerging infections, transfusion safety, and epidemiology. , 2003, The New England journal of medicine.

[8]  H. V. van Houwelingen,et al.  A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidates , 2003, Transplantation.

[9]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[10]  R. Lanciotti,et al.  Transmission of West Nile virus through blood transfusion in the United States in 2002. , 2003, The New England journal of medicine.

[11]  R. Sorelle.  United Network for Organ Sharing. , 1997, Circulation.

[12]  L. Petersen,et al.  West Nile Virus: A Primer for the Clinician , 2002, Annals of Internal Medicine.

[13]  S. Pitlik,et al.  Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[14]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[15]  B. Biggerstaff,et al.  Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002 , 2003, Transfusion.

[16]  T. Monath.  Prospects for Development of a Vaccine against the West Nile Virus , 2001, Annals of the New York Academy of Sciences.

[17]  F. Delmonico.  Cadaver donor screening for infectious agents in solid organ transplantation. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.